EXPRESSION OF CANCER STEM CELL’S MARKER (EPCAM) IN COLORECTAL ADENOCARCINOMA

Thanh Liêm Tiền

Main Article Content

Abstract

Background: Epithelial Cell Adhesive Molecule (EPCAM) is a glycoprotein involved in the development and metastasis of colon adenocarcinoma. Objectives: we investigated the expression of EPCAM and its relationship with pathological characteristics of colorectal adenocarcinoma, particularly the pTNM stage.  Materials and methods: A cross-sectional descriptive study was conducted on 102 patients diagnosed with colon adenocarcinoma at 30-4 Hospital. Using immunohistochemical staining with EPCAM markers on paraffin blocks. Results: No case was negative. Expression according to Mokhtari’s evaluation method is as follows: 52.9% strong positive, 25.5% moderate to strong positive, 9.8% moderate positive, 11.8% weak positive; According to Spizzo’s evaluation method is as follows: 34.3% strong positive, 36.3% moderate positive, 29.4% weak positive. The difference in expression patterns of EPCAM with average ages is statistically significant (p<0.05) and the negative association between EPCAM expression patterns and average ages is statistically significant (p<0.001).  Conclusions: The expression pattern of EPCAM differs between ages and positive EPCAM expression decreases with increasing age.

Article Details

References

1. Ferlay J., Siegel RL., Laversanne M., et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer Journal Clinicians. 2021, vol.71, pp. 209–249.
2. Siegel RL., Miller KD., Sauer AG., et al. Colorectal Cancer Statistics. CA Cancer Journal for Clinicians. 2020, vol.70, pp. 145–164.
3. Han S., Zong S., Shi Q., et al. Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis. eBioMedicine. 2017, vol.20, pp. 61–69.
4. Kalantari E., Taheri T., Fata S., et al. Significant co-expression of putative cancer stem cell markers, EpCAM and CD166, correlates with tumor stage and invasive behavior in colorectal cancer. World Journal of Surgical Oncology. 2022, vol.20(15), 11 pages.
5. Mokhtari M, Zakerzade Z. EPCAM Expression in Colon Adenocarcinoma and Its Relationship with TNM Staging. Advanced Biomedical Research. 2017, vol.6(56), doi: 10.4103/2277-9175.205529.
6. Spizzo G., Fong D., Wurm M., et al. EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis. Journal Clinical Pathology. 2011, vol.64, pp.415-420. doi:10.1136/jcp.2011.090274.
7. Abdelaziz LA, Megahed OA, Harb OA., et al. Stem Cell Markers Epithelial Cell Adhesion Molecule (EpCAM) & Cluster of Differentiation (CD44) Expression in Colon Cancer Patients in Relation to Prognosis and Survival. International Journal of Science and Research (IJSR). 2017, vol.6(2), pp.994-1005.
8. Gaghana LO, Miskad UA, Cangara MH, et al. The Relationship Between Expression of EpCAM Cancer Stem Cell Marker with Histopathological Grading, Lymphovascular Invasion, and Metastases in Colorectal Adenocarcinoma. Asian Pacific Journal of Cancer Prevention. 2023, vol.24 (3), pp.929-934.